The data illustrate that several patients remained on zenocutuzumab well beyond progression, including multiple patients who continued treatment for more than one- or two-years post-progression.
Caroline Banton has 6+ years of experience as a writer of business and finance articles. She also writes biographies for Story Terrace. Eric's career includes extensive work in both public and ...
The Ethiopian Neonatal Network (ENN) represents one of the first low-income country neonatal quality improvement (QI) ...
*For a limited time only. $2,000 off and a free toilet (install included) with the purchase and installation of a Safe Step Walk-In Tub. Note alternative offer of $1,000 off and a free toilet (install ...